Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 4, 2009, Pages 616-624

  Yi, Li Tao ^a   Xu, Qun ^a   Li, Yu Cheng ^a   Yang, Lei ^a   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Antidepressant like synergism; Compatibility; Ginger rhizome; Magnolia bark; Synergism

Indexed keywords

ESSENTIAL OIL; FLUOXETINE; GINGER EXTRACT; GINGER RHIZOME ESSENTIAL OIL; GINGER RHIZOME POLYSACCHARIDE; HONOKIOL; HONOKIOL PLUS MAGNOLOL; MAGNOLIA BARK POLYSACCHARIDE; MAGNOLIA EXTRACT; MAGNOLOL; NORADRENALIN; POLYSACCHARIDE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARK; BEHAVIOR; CHINESE MEDICINE; CONGENITAL MALFORMATION; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; GINGER; IMMOBILIZATION; MAGNOLIACEAE; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; RHIZOME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; EXPLORATORY BEHAVIOR; GINGER; IMMOBILITY RESPONSE, TONIC; MALE; MANGIFERA; MICE; MICE, INBRED ICR; NOREPINEPHRINE; PHYTOTHERAPY; PLANT EXTRACTS; RHIZOME; SEROTONIN; SWIMMING;

EID: 67349176647     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.03.001     Document Type: Article

References (54)

1. Banerjee S., Sharma R., Kale R.K., and Rao A.R. Influence of certain essential oils on carcinogen-metabolizing enzymes and acid-soluble sulfhydryls in mouse liver. Nutr Cancer 21 (1994) 263-269
2. Bhattarai S., Tran V.H., and Duke C.C. Stability of [6]-gingerol and [6]-shogaol in simulated gastric and intestinal fluids. J Pharm Biomed Anal 45 (2007) 648-653
3. Bourin M., Mocaër E., and Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 29 (2004) 126-133
4. Cabib S., Zocchi A., and Puglisi-Allegra S. A comparison of the behavioral effects of minaprine, amphetamine and stress. Psychopharmacology (Berl) 121 (1995) 73-80
5. Cabib S., Orsini C., Le Moal M., and Piazza P.V. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 289 (2000) 463-465
6. Cabib S., Puglisi-Allegra S., and Ventura R. The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res 130 (2002) 103-109
7. Chrubasik S., Pittler M.H., and Roufogalis B.D. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 12 (2005) 684-701
8. Commission of Chinese Materia Medica, Ministry of Health People's Republic of China. Chinese Materia Medica. Shanghai: Shanghai scientific & Technical Publishers, 1999.
9. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav R 29 (2005) 571-625
10. Curzon G., and Green A.R. Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Brit J Pharmacol 39 (1970) 653-655
11. DeBattista C., Sofuoglu M., and Schatzberg A.F. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. Biol Psychiatry 44 (1998) 341-347
12. de la Gándara J., Rojo J.E., Ros S., Agüera L., and de Pedro J.M. Neuropharmacological basis of combining antidepressants. Acta Psychiatr. Scand 36 (2005) 11-13
13. Delgado P., and Moreno F. Antidepressants and the brain. Int Clin Psychopharmacol 14 (1999) 9-16
14. Detke M.J., Rickels M., and Lucki I. Active behavior in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121 (1995) 66-72
15. Dhingra D., and Valecha R. Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests. Med Sci Monit 13 (2007) 155-161
16. Dodd S., Horgan D., Malhi G.S., and Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disorders 89 (2005) 1-11
17. Engleman E.A., Perry K.W., Mayle D.A., and Wong D.T. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor. Neuropsychopharmacol 12 (1995) 287-295
18. Grzanna R., Phan P., Polotsky A., Lindmark L., and Frondoza C.G. Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med 10 (2004) 1009-1013
19. Guo Y.S., Kong L.D., Wang Y.M., and Huang Z.Q. Antidepressant evaluation of polysaccharides from a Chinese herbal medicine Banxia-Houpu decoction. Phytother Res 18 (2004) 204-207
20. Hou Y.C., Chao P.D., and Chen S.Y. Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats. Am J Chin Med 28 (2000) 379-384
21. Jiang S.Z., Wang N.S., and Mi S.Q. Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats. Biopharm Drug Dispos 29 (2008) 529-537
22. Kabuto H., Nishizawa M., Tada M., Higashio C., Shishibori T., and Kohno M. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem Res 30 (2005) 325-332
23. Kyung K.S., Gon J.H., Geun K.Y., Sup J.J., Suk W.J., and Ho K.J. 6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury. Eur J Neurosci 24 (2006) 1042-1052
24. Lam R.W., Wan D.D., Cohen N.L., and Kennedy S.H. Combining antidepressants for treatment-resistant depression: a review. J Clin Psychiatry 63 (2002) 685-693
25. Lei Z.J., Zhang Z.Y., Wang P., Yao Y.F., and Wu H.Q. Studies on constituents of the extracts of Magnoliae officinalis using supercritical fluid extraction with carbon dioxide. Chinese J Mod Appl Pharm 17 (2000) 13-14
26. Lim W.C., Seo J.M., Lee C.I., Pyo H.B., and Lee B.C. Stimulative and sedative effects of essential oils upon inhalation in mice. Arch Pharm Res 28 (2005) 770-774
27. Mei S.L., Zheng Q.X., and Zou G.M. GC-MS analysis on essential oil of ginger. J Jilin Inst Chem Technol 22 (2005) 11-13
28. Nakamura Y., Yoshida C., Murakami A., Ohigashi H., Osawa T., and Uchida K. Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes. FEBS Lett 572 (2004) 245-250
29. Nakazawa T., Yasuda T., and Ohsawa K. Metabolites of orally administered Magnolia officinalis extract in rats and man and its antidepressant-like effects in mice. J Pharm Pharmacol 55 (2003) 1583-1591
30. Nutt D.J. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69 (2008) 4-7
31. Papakostas G.I., Fava M., and Thase M.E. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biol Psychiatry 63 (2008) 699-704
32. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
33. Qiu J. Back to the future" for Chinese herbal medicines. Nat Rev Drug Discov 6 (2007) 506-507
34. Rénéric J.P., and Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) 136 (1998) 190-197
35. Rubio G., San L., López-Muñoz F., and Alamo C. Reboxetine adjunct for partial or nonresponders to antidepressant treatment. J Affect Disorders 81 (2004) 67-72
36. Stahl S.M. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (2000), Cambridge University Press, Cambridge 283-293
37. Staub A.M. Removal of proteins. Sevag method. Methods Carbohydr Chem 5 (1965) 5-6
38. Stermitz F.R., Lorenz P., Tawara J.N., Zenewicz L.A., and Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 97 (2000) 1433-1437
39. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 (1985) 367-370
40. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163 (2006) 28-40
41. Tsai T.H., Lee T.F., Chen C.F., and Wang L.C. Modulatory effects of magnolol on potassium-stimulated 5-hydroxytryptamine release from rat cortical and hippocampal slices. Neurosci Lett 186 (1995) 49-52
42. Vandermaelen C.P., and Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 289 (1983) 109-113
43. Wang L.H., Gai Y.M., Yuan C., Zeng L., and Jia N. Pharmacokinetics profile of magnolol and honokiol: an experimental study in Wistar rats. Qianwei J Medicine 21 (2004) 137-139
44. Wang L., Zhou G.B., Liu P., Song J.H., Liang Y., Yan X.J., et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 105 (2008) 4826-4831
45. Wei F.X., Han J., Wang Q.L., Wang J.M., Cheng Y.H., and Shi Y.H. Technique of supercritical fluid extraction-fractionation for gingerol. Fine Chem 21 (2004) 269-272
46. Welch A.S., and Welch B.L. Solvent extraction method for simultaneous determination of norepinephrine, dopamine, serotonin, and 5-hydroxyindoleacetic acid in a single mouse brain. Anal Biochem 30 (1969) 161-179
47. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2001) 401-409
48. Xu Q., Yi L.T., Pan Y., Wang X., Li Y.C., Li J.M., et al. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 715-725
49. Yamahara J., Huang Q.R., Li Y.H., Xu L., and Fujimura H. Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull 38 (1990) 430-431
50. Yan B., Wang D.Y., Xing D.M., Ding Y., Wang R.F., Lei F., et al. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol Biochem Behav 78 (2004) 319-325
51. Zhang Z.K. Treatment of globus hystericus by modified Si-Qi decoction. Shaanxi J TCM 18 (1997) 509
52. Zhang L.C. Clinical examples of "Banxia Houpu decoction. Shanghai J TCM 37 (2003) 19-20
53. Zhang L., Hu H.B., Huang C.Y., Han Y., and Xia C. Studies on the composition of polysaccharide from Bupleurum scorzonerifolium. Chinese Traditional Herbal Drug 31 (2000) 647-648
54. Zangen A., Overstreet D.H., and Yadid G. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J Neurochem 69 (1997) 2477-2483